← Back to catalogue

BD BBL™ Sensi-Disc™ Cinoxacin - 100 µg

FDA UDI

Class II (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD BBL™ Sensi-Disc™ Cinoxacin - 100 µg FDA UDI
Generic Name
Antibacterial susceptibility testing disc IVD FDA UDI
Device Name
BD BBL™ Sensi-Disc™ Cinoxacin - 100 µg FDA UDI
Model / Reference
231599 FDA UDI
Description
BD BBL™ Sensi-Disc™ Cinoxacin - 100 µg FDA UDI

Identifiers

Catalog Number
231599 FDA UDI
Primary DI / UDI-DI
30382902315996 FDA UDI
510(k) Number
K800540 FDA UDI
FDA Product Code
JTN FDA UDI
GMDN Term
Antibacterial susceptibility testing disc IVD FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.1620 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Antibacterial susceptibility testing disc IVD

BD BBL™ Sensi-Disc™ Cinoxacin - 100 µg by Becton Dickinson And Company — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Antibacterial susceptibility testing disc IVD.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a2a7aa7a-a2d2-44a8-b689-f660556efa4b 37 fields · synced Jun 6, 2026